Skip to content
value.today

Applied Stemcell Inc.

🇺🇸 Sunnyvale, California, USABiotechnologyFounded 2008
Total raised
$24 M
3 rounds on record
Latest round
$19 M
May 2016
First round on record
Mar 2010
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Applied Stemcell Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2016$19 MNo. 3$10 to $50 million

Applied Stemcell Inc.: Raise no. 3, May 2016

Investors in this round

6 investors had bought by the notice of Oct 11, 2016: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $19 M offered
Smallest investment taken
$1
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ruhong Jiang · Executive Officer, Director
  • Guoliang Yu · Director
  • Zhenyu Xiao · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Conversion of convertible note debt into Series D Preferred Stock, additional issuance of Series D Preferred Stock and the Common Stock issuable upon the conversion of such Preferred Stock.”

Signed by Ruhong Jiang, Ph.D., Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 11, 2016. Read the notice at the SEC.

equity, debtSEC
Mar 2013$3 MNo. 2$2 to $10 million

Applied Stemcell Inc.: Raise no. 2, Mar 2013

Investors in this round

25 investors had bought by the notice of Mar 26, 2013: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Ruhong Jiang · Executive Officer, Director
  • Dean Tsao · Director
  • Grace Tian · Director
  • Guoliang Yu · Director
  • James Zhu · Director
  • Shengjiang Liu · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Issuance of Series C Preferred Stock and convertible promissory notes issuable into Series C Preferred Stock and the Common Stock issuable upon conversion of such Preferred Stock.”

Signed by Ruhong Jiang, Ph.D., Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 26, 2013. Read the notice at the SEC.

equity, debtSEC
Mar 2010$2 MNo. 1Under $2 million

Applied Stemcell Inc.: Raise no. 1, Mar 2010

Investors in this round

16 investors had bought by the notice of Mar 19, 2010: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in California

People named in the notice

  • Ruhong Jiang · Executive Officer, Director
  • Grace Tian · Director
  • Guoliang Yu · Director
  • James Zhu · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Partial conversion of convertible note debt into Series B Preferred Stock, additional issuance of Series B Preferred Stock and the underlying Common Stock ussuable upon conversion of such Series B Preferred Stock”

Signed by Ruhong Jiang, Ceo. Source: SEC Form D, newest notice filed Mar 19, 2010. Read the notice at the SEC.

equity, debtSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Applied Stemcell Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2016).

    SEC Form D · Oct 2016

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2016

That is all the official record says: Applied Stemcell Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Applied Stemcell Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 25 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Applied Stemcell Inc.
NameRoleNamed in
Ruhong JiangExecutive officerOct 2016
Guoliang YuDirectorOct 2016
Ruhong JiangDirectorOct 2016
Zhenyu XiaoDirectorOct 2016
Dean TsaoDirectorMar 2013
Grace TianDirectorMar 2013
James ZhuDirectorMar 2013
Shengjiang LiuDirectorMar 2013